CompletedNCT01403662
Minocycline Added to Care for Depression Related to Bipolarity
About this title
Evaluating the Efficacy of Adjunctive Minocycline for the Treatment of Bipolar Depression
Read the official source — NCT01403662Medication studyAges 18–65Canada
Understand this study
Who was this study for?
This study was for people with bipolarity. Listed age limits: 18 years to 65 years. Other eligibility criteria applied.
- Listed locations
- TorontoSee all locations and recruitment
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Study information
Study start dateJuly 2011
- Recruitment status
- Completed
- Enrollment listed in the registry
- 29
- Sponsor
- University Health Network, Toronto
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
- Locations
- Canada
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT01403662
- Official title
Show the full official title
A Pilot, Open-label, 8-Week Study Evaluating the Efficacy, Safety, and Tolerability of Adjunctive Minocycline for the Treatment of Bipolar Depression
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Toronto
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is University Health Network, Toronto, a university.
Did this study involve medication?
Yes. The study involved medication, including Minocycline.
Who was this study for?
This study was for people with bipolarity. Listed age limits: 18 years to 65 years. Other eligibility criteria applied.
